Reagila 3 mg hard capsules clinical trials

A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 years of age) with Schizophrenia

This study is looking at a medicine called cariprazine for young people aged 13 to 17 who have schizophrenia. It compares different doses of cariprazine with a dummy pill (placebo) over 6 weeks to see if it helps with symptoms and is safe.